Stan

A variety of different initiatives that she's involved with, including pharmacogenetics,

genomics excuse me um and also patient outcomes as it relates to um to drugs and medications so you guys are second to none i i could frankly you know hand off the show and just we could the rest of us could just be quiet because i'm sure you have great insights so thanks for being with us on health chatter so all right so let me start this thing out um

Yeah.

Frankly in the news, in the news, in today's paper, nationally, right.

And is makers of obesity drugs are to cut prices so that they can widen coverage and provide obesity drugs easier for patients.

Okay.

So my question is, um,

You know, first and foremost, they might have been too expensive to begin with, but that's another issue altogether.

But what are we dealing with here?

Are we dealing with medications that are just easy peasy?

Let's just take the drugs and we don't have to worry about anything.

And obesity, these obesity drugs are certainly one angle on this.

So

Asia and Rhonda, give me your perspective on should we just medicate?

When in doubt, just medicate.

Forget exercise.

Forget eating properly.

Just take the drug.

And thank you very much.

You know, it's interesting.